Javascript must be enabled to continue!
Politically exposed entities: how to tailor PEP requirements to PEP owned legal entities
View through CrossRef
Purpose
This paper aims to address the money laundering risk posed by politically exposed person’s (PEP’s) controlled legal entities. International standards and national legislation require enhanced due diligence of political office holders but no specific requirements exist on entities controlled by PEPs. While regulators expect the stringent AML risk mitigation regarding this type of entities, financial institutions have no guidelines to follow. This gap produces inconsistent due diligence measures applied to entities with significant PEPs’ connection.
Design/methodology/approach
The paper uses comparative analysis to identify discrepancies between legal requirements and their interpretation. Moreover, an empirical approach results in a standardised solution to address these discrepancies.
Findings
The paper defines the concept of politically exposed entities and the applicable due diligence framework. Anticipating legislative measures, it proposes to introduce this concept via best practices of financial institutions and private banking initiatives such as the Wolfsberg Group.
Research limitations/implications
The research addresses the topic from a legal point of view. However, the implementation of proposed ideas depends on decisions which are political by nature and are not within the scope of this paper.
Practical implications
The paper aims at stimulating a debate in both the private and public sector to form a consistent approach to AML due diligence of legal entities associated to PEPs.
Originality/value
This paper responds to an identified need to study how legal entities connected to PEPs should be defined and monitored.
Title: Politically exposed entities: how to tailor PEP requirements to PEP owned legal entities
Description:
Purpose
This paper aims to address the money laundering risk posed by politically exposed person’s (PEP’s) controlled legal entities.
International standards and national legislation require enhanced due diligence of political office holders but no specific requirements exist on entities controlled by PEPs.
While regulators expect the stringent AML risk mitigation regarding this type of entities, financial institutions have no guidelines to follow.
This gap produces inconsistent due diligence measures applied to entities with significant PEPs’ connection.
Design/methodology/approach
The paper uses comparative analysis to identify discrepancies between legal requirements and their interpretation.
Moreover, an empirical approach results in a standardised solution to address these discrepancies.
Findings
The paper defines the concept of politically exposed entities and the applicable due diligence framework.
Anticipating legislative measures, it proposes to introduce this concept via best practices of financial institutions and private banking initiatives such as the Wolfsberg Group.
Research limitations/implications
The research addresses the topic from a legal point of view.
However, the implementation of proposed ideas depends on decisions which are political by nature and are not within the scope of this paper.
Practical implications
The paper aims at stimulating a debate in both the private and public sector to form a consistent approach to AML due diligence of legal entities associated to PEPs.
Originality/value
This paper responds to an identified need to study how legal entities connected to PEPs should be defined and monitored.
Related Results
Physiological responses to positive expiratory pressure breathing a comparison of the PEP bottle and the PEP mask.
Physiological responses to positive expiratory pressure breathing a comparison of the PEP bottle and the PEP mask.
BACKGROUND: In the intensive care unit we have observed that patients have different adherence to 2 commonly used positive-expiratory-pressure (PEP) therapy devices: the PEP bottle...
The Particle Environment Package (PEP) for the JUICE mission: Ready to go!
The Particle Environment Package (PEP) for the JUICE mission: Ready to go!
<p><strong>1. PEP objectives</strong></p>
<p>The PEP suite explores the particle populations in the Jovian sys...
THE ANALOGY OF STATUTE AND THE ANALOGY OF LAW AS DOCTRINAL INSTRUMENTS FOR LEGAL RESPONSE TO ECONOMIC CHALLENGES
THE ANALOGY OF STATUTE AND THE ANALOGY OF LAW AS DOCTRINAL INSTRUMENTS FOR LEGAL RESPONSE TO ECONOMIC CHALLENGES
Ukraine's contemporary legal system is undergoing a period of significant transformation, which necessitates not only a robust and stable legal framework, but also a flexible doctr...
SII in combination with hsCRP predict the risk of pancreatitis after endoscopic retrograde cholangiopancreatography
SII in combination with hsCRP predict the risk of pancreatitis after endoscopic retrograde cholangiopancreatography
Abstract
Objective
To investigate the relationship between the development of post-ERCP pancreatitis(PEP)and the systemic immune-inflammatory index (SII) and high-sensitiv...
Particle Environment Package (PEP) for the Juice Mission: Current Status
Particle Environment Package (PEP) for the Juice Mission: Current Status
The Particle Environment Package (PEP) onboard ESA’s Jupiter Icy Moons Explorer (JUICE) provides particle measurements to address three overarching science questions:How does Jupit...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Corporations in Ukrainian Law
Corporations in Ukrainian Law
This article deals with the special development of the company (or rather corporate) law in Ukrainian legal system. The current legislation does not set the concept of corporation....
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel
AbstractGlioma presents one of the most malignant brain tumors and the therapeutic effect is often limited due to the existence of brain tumor barrier. Based on interleukin-13 rece...

